Glutamate-induced changes in the pattern of hippocampal dendrite outgrowth: a role for calcium-dependent pathways and the microtubule cytoskeleton

J Neurobiol. 2000 May;43(2):159-72. doi: 10.1002/(sici)1097-4695(200005)43:2<159::aid-neu6>3.0.co;2-n.

Abstract

Glutamate regulation of a variety of aspects of dendrite development may be involved in neuronal plasticity and neuropathology. In this study, we examine the calcium-dependent pathways and alterations in the microtubule (MT) cytoskeleton that may mediate glutamate-induced changes in the pattern of dendrite outgrowth. We used Fura-2 AM and inhibitors of the calcium-dependent proteins, calmodulin and calpain, to identify the role of specific calcium-dependent pathways in glutamate-regulated dendrite outgrowth. Additionally, we used a quantitative fluorescence technique to correlate changes in MT levels with glutamate-induced changes in dendrite outgrowth. We show that the intracellular calcium concentration ([Ca(2+)](i)) changes in a biphasic manner over a 12-h period in the presence of glutamate. A transient increase in [Ca(2+)](i) over the first hour of glutamate exposure correlated with a calmodulin-associated increase in the rate of dendrite outgrowth, whereas a sustained increase in [Ca(2+)](i) was correlated with calpain-associated dendrite retraction. Quantitative fluorescence measurements showed no net change in the level of MTs during calmodulin-associated increases in dendrite outgrowth, but showed a significant decline in the level of MTs during calpain-associated dendrite retraction. These findings provide insights into the intracellular mechanisms involved in activity-dependent regulation of dendrite morphology during development and after pathology.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Calcium / metabolism*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytoskeleton / metabolism*
  • Dendrites / drug effects
  • Dendrites / metabolism*
  • Dipeptides / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Fluoresceins
  • Glutamic Acid / metabolism*
  • Glutamic Acid / pharmacology
  • Glycoproteins / pharmacology
  • Growth Cones / drug effects
  • Growth Cones / metabolism
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Imidazoles / pharmacology
  • Microscopy, Fluorescence
  • Microtubule Proteins / metabolism
  • Microtubules / drug effects
  • Microtubules / metabolism*
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Nocodazole / pharmacology
  • Paclitaxel / pharmacology

Substances

  • Antineoplastic Agents
  • Cysteine Proteinase Inhibitors
  • Dipeptides
  • Enzyme Inhibitors
  • Fluoresceins
  • Glycoproteins
  • Imidazoles
  • Microtubule Proteins
  • calpain inhibitors
  • Glutamic Acid
  • calmidazolium
  • 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein
  • Paclitaxel
  • Nocodazole
  • Calcium
  • calpain inhibitor III